-
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Study ID: ONC99274 (AREN1921)
PI: Maggie Fader.
Más detalles sobre este estudio
-
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body (ON-TRK)
Study ID: ONC99126 (ON-TRK)
PI: Ossama Maher.
Más detalles sobre este estudio
-
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
Study ID: ONC24008 (BCC016)
PI: Ossama Maher.
Más detalles sobre este estudio
-
Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours (P3BEP)
Study ID: ONC99078 (AGCT1532)
PI: Maggie Fader.
Más detalles sobre este estudio
-
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
Study ID: ONC23174 (CONNECT1906)
PI: Ziad Khatib.
Más detalles sobre este estudio
-
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Study ID: ONC23006 (ANHL2121)
PI: Maggie Fader.
Más detalles sobre este estudio
-
MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
Study ID: ONC23127 (CONNECT2108)
Más detalles sobre este estudio
-
ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
Study ID: ONC23173 (CONNECT1905)
PI: Ziad Khatib.
Más detalles sobre este estudio
-
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Study ID: ONC99101 (APAL2020SC)
PI: Maggie Fader.
Más detalles sobre este estudio
-
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy (PEDS-PLAN)
Study ID: ONC99113 (NMTRC012)
PI: Guillermo De Angulo.
Más detalles sobre este estudio
-
A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy
Study ID: ONC23162 (I3Y-MC-JPEH)
PI: Ziad Khatib.
Más detalles sobre este estudio
-
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma
Study ID: ONC23150 (ACCL1931)
PI: Maggie Fader.
Más detalles sobre este estudio
-
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Study ID: ONC99271 (AHOD2131)
PI: Maggie Fader.
Más detalles sobre este estudio
-
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
Study ID: ONC99276 (ARST2032)
PI: Maggie Fader.
Más detalles sobre este estudio
-
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Study ID: ONC25006 (ACNS2321)
PI: Ziad Khatib.
Más detalles sobre este estudio
-
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Study ID: ONC23118 (BCC018)
PI: Maggie Fader.
Más detalles sobre este estudio
-
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Study ID: ONC24030 (ANBL2131)
PI: Maggie Fader.
Más detalles sobre este estudio
-
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Study ID: ONC99077 (AGCT1531)
PI: Maggie Fader.
Más detalles sobre este estudio
-
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Study ID: ONC99062 (AALL1732)
PI: Maggie Fader.
Más detalles sobre este estudio
-
A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma
Study ID: ONC99073 (ACNS1831)
PI: Ziad Khatib.
Más detalles sobre este estudio
-
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Study ID: ONC99074 (ACNS1833)
PI: Ziad Khatib.
Más detalles sobre este estudio
-
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Study ID: ONC99100 (AOST2031)
PI: Ziad Khatib.
Más detalles sobre este estudio
-
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
Study ID: ONC99099 (ACNS2021)
PI: Ziad Khatib.
Más detalles sobre este estudio
-
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
Study ID: ONC24032 (ARAR2221)
PI: Maggie Fader.
Más detalles sobre este estudio
-
A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia
Study ID: ONC24004 (AALL2121)
PI: Maggie Fader.
Más detalles sobre este estudio
-
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
Study ID: ONC99060 (AALL1621)
PI: Maggie Fader.
Más detalles sobre este estudio
-
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Study ID: NEU23013 (C4951002-BHV3000-311)
PI: Wilson Heredia-Nunez.
Más detalles sobre este estudio
-
Focal Cerebral Arteriopathy Steroid Trial (FOCAS)
Study ID: NEU23170 (FOCAS)
PI: Anuj Jayakar.
Más detalles sobre este estudio
-
Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG)
Study ID: NEU23134 (BT016)
PI: Toba Niazi.
Más detalles sobre este estudio
-
A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy (EXPAND)
Study ID: NEU23003 (N01269)
PI: Anuj Jayakar.
Más detalles sobre este estudio
-
A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex (EpiCom)
Study ID: NEU23103 (JZP926-402)
PI: Paula Schleifer.
Más detalles sobre este estudio
-
Phase 3 Efficacy and Safety Study of GTX-102 in Pediatric Subjects with AS (Aspire)
Study ID: NEU24001 (GTX-102-CL301)
PI: Paula Schleifer.
Más detalles sobre este estudio
-
Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy
Study ID: NEU99201 (NBI-98854-DCP3018)
PI: Migvis Monduy.
Más detalles sobre este estudio
-
A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy
Study ID: NEU24007 (EP0224)
PI: Anuj Jayakar.
Más detalles sobre este estudio